Modeling mechanisms underlying differential inflammatory responses to COVID-19 in type 2 diabetes using a patient-derived microphysiological organ-on-a-chip system

Human Liver-on-a-chip microphysiological system was developed to model and COVID-19 infection in T2D patients and to screen drugs to mitigate cytokine storm syndrome and expedite drug development.